Kaletra 200 mg/1 (Lopinavir and Ritonavir TABLET, FILM COATED) 200 mg/1

Kaletra 200 mg/1 is a combination of lopinavir and ritonavir, used to manage HIV infection. This oral medication is designed to support antiviral therapy, helping to control the virus in the body.

Strength

200 mg/1

Pack Size

120 TABLET, FILM COATED in 1 BOTTLE (0074-4014-12)

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Kaletra 200 mg/1 is primarily used in the treatment of HIV infection. It works by combining lopinavir and ritonavir to enhance the effectiveness of the antiviral therapy. This medication is often prescribed as part of a comprehensive treatment plan to manage HIV and improve patient outcomes. What is Kaletra used for? It is used to help control HIV infection by reducing the amount of virus in the body.

Side Effects

Common effects of Kaletra 200 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea. Some individuals might experience headaches or changes in taste. These effects vary among users and are not experienced by everyone taking the medication.

Precautions & Warnings

Kaletra 200 mg/1 should be handled with care, especially regarding interactions with other medications. It is important to follow the advice of a healthcare provider when starting or adjusting any treatment regimen. Always store the medication as directed and keep it out of reach of children.

Avoid Interactions

Kaletra 200 mg/1 can interact with a variety of medications, including those metabolized by the liver's cytochrome P450 system. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Kaletra.

Frequently Asked Questions

Kaletra 200 mg/1 is used to manage HIV infection by combining lopinavir and ritonavir to enhance antiviral therapy.

Kaletra 200 mg/1 is taken orally, typically as directed by a healthcare provider. Always follow the prescribed dosage and administration instructions.

Common side effects may include gastrointestinal discomfort, nausea, diarrhea, headaches, and changes in taste.

Kaletra 200 mg/1 can interact with many medications, so it is important to consult a healthcare provider before combining it with other treatments.

Long-term use of Kaletra 200 mg/1 should be monitored by a healthcare provider to ensure safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.